D-1500-2016 Class II Terminated
FDA drug recall D-1500-2016 was initiated by Hospira Inc. on Aug 15, 2016 and is designated Class II. Reason for recall: Discoloration: Firm received complaints of product discoloration and particulates. The recall status is terminated (terminated Aug 23, 2019). Affected quantity: 24000 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 21, 2016
- Initiation Date
- Aug 15, 2016
- Termination Date
- Aug 23, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24000 vials
Product description
Reason for recall
Distribution pattern
Product was distributed nationwide. 23700 units distributed to US and Puerto Rico, and Bahamas was 300 units. 30 units returned by customer and destroyed internally.
Code information
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1500-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.